Altered insulin and glucagon secretion in treated genetic hyperlipemia: a mechanism of theraphy?

Eaton RP, Oase R, Schade DS

DOI: 10.1016/0026-0495(76)90082-2
Published: 1976 Mar
Container: Metabolism: clinical and experimental
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/0026-0495-76-90082-2,
  title = {Altered insulin and glucagon secretion in treated genetic hyperlipemia: a mechanism of theraphy?},
  author = {Eaton RP and Oase R and Schade DS},
  year = {1976},
  journal = {Metabolism: clinical and experimental},
  doi = {10.1016/0026-0495(76)90082-2},
  url = {https://doi.org/10.1016/0026-0495(76)90082-2}
}

RIS

TY  - JOUR
TI  - Altered insulin and glucagon secretion in treated genetic hyperlipemia: a mechanism of theraphy?
AU  - Eaton RP
AU  - Oase R
AU  - Schade DS
PY  - 1976
JO  - Metabolism: clinical and experimental
DO  - 10.1016/0026-0495(76)90082-2
UR  - https://doi.org/10.1016/0026-0495(76)90082-2
ER  -

APA

RP, E., R, O., & DS, S. (1976). Altered insulin and glucagon secretion in treated genetic hyperlipemia: a mechanism of theraphy?. Metabolism: clinical and experimental. https://doi.org/10.1016/0026-0495(76)90082-2

Source records

pubmed · retrieved 2026-09-26T01:47:29.432Z